Publication:
Protective effects of melatonin on changes occurring in the experimental autoimmune encephalomyelitis model of multiple sclerosis.

Loading...
Thumbnail Image

Date

2022-01-09

Authors

Escribano, Begoña Maria
Muñoz-Jurado, A
Caballero-Villarraso, J
Valdelvira, M E
Giraldo, A I
Paz-Rojas, E
Gascon, F
Santamaria, A
Agüera, E
Tunez, Isaac

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Melatonin has been related to the pathophysiology of multiple sclerosis (MS), and its anti-inflammatory and immunomodulatory properties have been proved in numerous neurodegenerative diseases. This study aimed to find out whether a melatonin supplement in MS is able to act as a benefit to its clinical status, i.e. oxidative stress, inflammation and indirect biomarkers of bacterial dysbiosis, lipopolysaccharide (LPS) and LPS-binding protein (LBP), verifying its therapeutic potential and its possible clinical use in patients with MS. The animal MS model, experimental autoimmune encephalomyelitis (EAE), was employed whereby 25 male Dark Agouti rats (5 animals per group) were divided into: a control group (not manipulated); a control+vehicle group; a control+melatonin group; an EAE group; an EAE+melatonin group. Melatonin was administered daily for 51 days, at a dose of 1 mg/kg body weight/i.p., once a day, five days a week. The results from the administration of melatonin demonstrated an improvement in clinical status, a diminution in oxidative stress and inflammation, as well as in bacterial dysbiosis. Melatonin could play an effective role against MS, either alone or as a therapy combined with traditional agents.

Description

MeSH Terms

Animals
Biomarkers
Encephalomyelitis, autoimmune, experimental
Humans
Male
Melatonin
Mice
Mice, inbred C57BL
Multiple sclerosis
Oxidative stress
Rats

DeCS Terms

Animales
Biomarcadores
Encefalomielitis autoinmune experimental
Esclerosis múltiple
Estrés oxidativo
Melatonina
Ratones endogámicos C57BL

CIE Terms

Keywords

Bacterial lipopolysaccharide, Experimental autoimmune encephalomyelitis, Glutathione redox system, Melatonin, Multiple sclerosis, Oxidative stress, AGS - Norte de Córdoba

Citation

Escribano BM, Muñoz-Jurado A, Caballero-Villarraso J, Valdelvira ME, Giraldo AI, Paz-Rojas E, et al. Protective effects of melatonin on changes occurring in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Mult Scler Relat Disord. 2022 Feb;58:103520